USA: +1 347 690-0211 | UK: +44 2032 894158 | JAPAN: +81 50 5806 9039 | Translate : 

Year End Offer
report img

Therapeutic Drug Monitoring Market by Product (Consumables and Equipment), by Technology (Immunoassays, Colorimetric Immunoassays, Radioimmunoassays, Other immunoassays, and Chromatography-MS), by Class of Drug (Antiepileptic drugs, Antiarrhythmic drugs, Immunosuppressant drugs, Antibiotic drugs, Bronchodilator drugs, Psychoactive drugs, and Other drug classes), by End user (Hospital laboratories, Commercial/private laboratories, and Other end users) and Regions: Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

Covid-19

Therapeutic Drug Monitoring Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Insights

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the therapeutic drug monitoring industry. The report analyzes and declares the historical and current trends analysis of the therapeutic drug monitoring industry and subsequently recommends the projected trends anticipated to be observed in the therapeutic drug monitoring market during the upcoming years.

The therapeutic drug monitoring market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire therapeutic drug monitoring market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of both volumes (Units) and value (USD Million) from FY 2016 – 2026.

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the therapeutic drug monitoring industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the therapeutic drug monitoring industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the therapeutic drug monitoring market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders the therapeutic drug monitoring involved in the entire value chain of the therapeutic drug monitoring industry. The market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the therapeutic drug monitoring sector. Key strategic developments in the therapeutic drug monitoring market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the therapeutic drug monitoring market are appropriately highlighted in the report.

The therapeutic drug monitoring market research report delivers an acute valuation and taxonomy of the therapeutic drug monitoring industry by practically splitting the market on the basis of different components, applications, end-user, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the therapeutic drug monitoring industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. Further, country-wise data for the therapeutic drug monitoring industry is provided for the leading economies of the world.

The global therapeutic drug monitoring industry is anticipated to provide budding opportunities to the manufacturers, vendors, and customers across the globe. The sudden rise of the COVID-19 pandemic level has a positive impact on the demand patterns of the therapeutic drug monitoring which is expected to propel the growth of the global market in the next 10 years. Additionally, increasing the use of TDM in traditional anticancer therapies, coupled with the growing number of organ transplant procedures across the globe are factors driving the growth of the global market. However, the reluctance of small hospitals to offer TDM services is a factor expected to hinder the growth of the global market in the near future.

The global therapeutic drug monitoring market is segmented on the basis of product, class of drug, technology, and end-user. On the basis of product type, the global market is categorized into consumables and equipment. Based on technology the global market is bifurcated into immunoassays, colorimetric immunoassays, radioimmunoassays, other immunoassays, and chromatography-MS. The global market is segmented into antiepileptic drugs, antiarrhythmic drugs, immunosuppressant drugs, antibiotic drugs, bronchodilator drugs, psychoactive drugs, and other drug classes, depending upon the class of the drugs. Also, the end-users in the global market include hospital laboratories, commercial/private laboratories, and other end users.

Some of the essential players operating in the therapeutic drug monitoring market, but not restricted to include Abbott Laboratories, Danaher Corporation, Biomérieux, Bühlmann Laboratories, Randox Laboratories Hoffmann-La Roche, Siemens Healthineers, Thermo Fisher Scientific, Bio-Rad Laboratories, and Sekisui Medical. Major companies in the global therapeutic drug monitoring market are trying to focus on the inorganic business strategies including launches of innovative products along with strategic partnerships.

logoThe taxonomy of the therapeutic drug monitoring market industry by its scope and segmentation is as follows:

logoGlobal Therapeutic Drug Monitoring Market: By Product

  • Consumables
  • Equipment
    • Immunoassay analyzers
    • Chromatography and MS detectors
    • Clinical chemistry analyzers

logoGlobal Therapeutic Drug Monitoring Market: By Technology

  • Immunoassays
    • Chemiluminescent immunoassays
    • Fluorescence immunoassays
  • Colorimetric Immunoassays
  • Radioimmunoassays
  • Other immunoassays
  • Chromatography-MS
    • Liquid Chromatography/Mass Spectrometry
    • Gas Chromatography-Mass Spectrometry

logoGlobal Therapeutic Drug Monitoring Market: By Class of Drug

  • Antiepileptic drugs
  • Antiarrhythmic drugs
  • Immunosuppressant drugs
  • Antibiotic drugs
  • Bronchodilator drugs
  • Psychoactive drugs
  • Other drug classes

logoGlobal Therapeutic Drug Monitoring Market: By End User

  • Hospital laboratories
  • Commercial/private laboratories
  • Other end users

logoGlobal Therapeutic Drug Monitoring Market: Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • The UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
key report pointers

Covid-19

Therapeutic Drug Monitoring Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Table of Content

  1. CHAPTER 1. Executive Summary
  2. CHAPTER 2. Therapeutic Drug Monitoring market – Product Analysis
    1. 2.1. Global Therapeutic Drug Monitoring Market – Product Overview
    2. 2.2. Global Therapeutic Drug Monitoring Market Share, by Product, 2018 & 2025 (USD Million)
    3. 2.3. Consumables
      1. 2.3.1. Global Consumables Therapeutic Drug Monitoring Market, 2016-2026 (USD Million)
    4. 2.4. Equipment
      1. 2.4.1. Global Equipment Therapeutic Drug Monitoring Market, 2016-2026 (USD Million)
  3. CHAPTER 3. Therapeutic Drug Monitoring market – Technology Analysis
    1. 3.1. Global Therapeutic Drug Monitoring Market – Technology Overview
    2. 3.2. Global Therapeutic Drug Monitoring Market Share, by Technology, 2018 & 2025 (USD Million)
    3. 3.3. Immunoassays
      1. 3.3.1. Global Immunoassays Therapeutic Drug Monitoring Market, 2016-2026 (USD Million)
    4. 3.4. Colorimetric Immunoassays
      1. 3.4.1. Global Colorimetric Immunoassays Therapeutic Drug Monitoring Market, 2016-2026 (USD Million)
    5. 3.5. Radioimmunoassays
      1. 3.5.1. Global Radioimmunoassays Therapeutic Drug Monitoring Market, 2016-2026 (USD Million)
    6. 3.6. Other immunoassays
      1. 3.6.1. Global Other immunoassays Therapeutic Drug Monitoring Market, 2016-2026 (USD Million)
    7. 3.7. Chromatography-MS
      1. 3.7.1. Global Chromatography-MS Therapeutic Drug Monitoring Market, 2016-2026 (USD Million)
  4. CHAPTER 4. Therapeutic Drug Monitoring market – Class of Drug Analysis
    1. 4.1. Global Therapeutic Drug Monitoring Market – Class of Drug Overview
    2. 4.2. Global Therapeutic Drug Monitoring Market Share, by Class of Drug, 2018 & 2025 (USD Million)
    3. 4.3. Antiepileptic drugs
      1. 4.3.1. Global Antiepileptic drugs Therapeutic Drug Monitoring Market, 2016-2026 (USD Million)
    4. 4.4. Antiarrhythmic drugs
      1. 4.4.1. Global Antiarrhythmic drugs Therapeutic Drug Monitoring Market, 2016-2026 (USD Million)
    5. 4.5. Immunosuppressant drugs
      1. 4.5.1. Global Immunosuppressant drugs Therapeutic Drug Monitoring Market, 2016-2026 (USD Million)
    6. 4.6. Antibiotic drugs
      1. 4.6.1. Global Antibiotic drugs Therapeutic Drug Monitoring Market, 2016-2026 (USD Million)
    7. 4.7. Bronchodilator drugs
      1. 4.7.1. Global Bronchodilator drugs Therapeutic Drug Monitoring Market, 2016-2026 (USD Million)
    8. 4.8. Psychoactive drugs
      1. 4.8.1. Global Psychoactive drugs Therapeutic Drug Monitoring Market, 2016-2026 (USD Million)
    9. 4.9. Other drug classes
      1. 4.9.1. Global Other drug classes Therapeutic Drug Monitoring Market, 2016-2026 (USD Million)
  5. CHAPTER 5. Therapeutic Drug Monitoring market – End User Analysis
    1. 5.1. Global Therapeutic Drug Monitoring Market – End User Overview
    2. 5.2. Global Therapeutic Drug Monitoring Market Share, by End User, 2018 & 2025 (USD Million)
    3. 5.3. Hospital laboratories
      1. 5.3.1. Global Hospital laboratories Therapeutic Drug Monitoring Market, 2016-2026 (USD Million)
    4. 5.4. Commercial/private laboratories
      1. 5.4.1. Global Commercial/private laboratories Therapeutic Drug Monitoring Market, 2016-2026 (USD Million)
    5. 5.5. Others
      1. 5.5.1. Global Others Therapeutic Drug Monitoring Market, 2016-2026 (USD Million)
  6. CHAPTER 6. Therapeutic Drug Monitoring market – Regional Analysis
    1. 6.1. Global Therapeutic Drug Monitoring Market Regional Overview
    2. 6.2. Global Therapeutic Drug Monitoring Market Share, by Region, 2018 & 2025 (Value)
    3. 6.3. North America
      1. 6.3.1. North America Therapeutic Drug Monitoring Market size and forecast, 2016-2026
      2. 6.3.2. North America Therapeutic Drug Monitoring Market, by Country, 2018 & 2025 (USD Million)
      3. 6.3.3. North America Therapeutic Drug Monitoring Market, by Product, 2016-2026
        1. 6.3.3.1. North America Therapeutic Drug Monitoring Market, by Product, 2016-2026 (USD Million)
      4. 6.3.4. North America Therapeutic Drug Monitoring Market, by Technology, 2016-2026
        1. 6.3.4.1. North America Therapeutic Drug Monitoring Market, by Technology, 2016-2026 (USD Million)
      5. 6.3.5. North America Therapeutic Drug Monitoring Market, by Class of Drug, 2016-2026
        1. 6.3.5.1. North America Therapeutic Drug Monitoring Market, by Class of Drug, 2016-2026 (USD Million)
      6. 6.3.6. North America Therapeutic Drug Monitoring Market, by End User, 2016-2026
        1. 6.3.6.1. North America Therapeutic Drug Monitoring Market, by End User, 2016-2026 (USD Million)
      7. 6.3.7. U.S.
        1. 6.3.7.1. U.S. Market size and forecast, 2016-2026 (USD Million)
      8. 6.3.8. Canada
        1. 6.3.8.1. Canada Market size and forecast, 2016-2026 (USD Million)
    4. 6.4. Europe
      1. 6.4.1. Europe Therapeutic Drug Monitoring Market size and forecast, 2016-2026
      2. 6.4.2. Europe Therapeutic Drug Monitoring Market, by Country, 2018 & 2025 (USD Million)
      3. 6.4.3. Europe Therapeutic Drug Monitoring Market, by Product, 2016-2026
        1. 6.4.3.1. Europe Therapeutic Drug Monitoring Market, by Product, 2016-2026 (USD Million)
      4. 6.4.4. Europe Therapeutic Drug Monitoring Market, by Technology, 2016-2026
        1. 6.4.4.1. Europe Therapeutic Drug Monitoring Market, by Technology, 2016-2026 (USD Million)
      5. 6.4.5. Europe Therapeutic Drug Monitoring Market, by Class of Drug, 2016-2026
        1. 6.4.5.1. Europe Therapeutic Drug Monitoring Market, by Class of Drug, 2016-2026 (USD Million)
      6. 6.4.6. Europe Therapeutic Drug Monitoring Market, by End User, 2016-2026
        1. 6.4.6.1. Europe Therapeutic Drug Monitoring Market, by End User, 2016-2026 (USD Million)
      7. 6.4.7. Germany
        1. 6.4.7.1. Germany Market size and forecast, 2016-2026 (USD Million)
      8. 6.4.8. France
        1. 6.4.8.1. France Market size and forecast, 2016-2026 (USD Million)
      9. 6.4.9. U.K.
        1. 6.4.9.1. U.K. Market size and forecast, 2016-2026 (USD Million)
      10. 6.4.10. Italy
        1. 6.4.10.1. Italy Market size and forecast, 2016-2026 (USD Million)
      11. 6.4.11. Spain
        1. 6.4.11.1. Spain Market size and forecast, 2016-2026 (USD Million)
      12. 6.4.12. Rest of Europe
        1. 6.4.12.1. Rest of Europe Market size and forecast, 2016-2026 (USD Million)
    5. 6.5. Asia Pacific
      1. 6.5.1. Asia Pacific Therapeutic Drug Monitoring Market size and forecast, 2016-2026
      2. 6.5.2. Asia Pacific Therapeutic Drug Monitoring Market, by Country, 2018 & 2025 (USD Million)
      3. 6.5.3. Asia Pacific Therapeutic Drug Monitoring Market, by Product, 2016-2026
        1. 6.5.3.1. Asia Pacific Therapeutic Drug Monitoring Market, by Product, 2016-2026 (USD Million)
      4. 6.5.4. Asia Pacific Therapeutic Drug Monitoring Market, by Technology, 2016-2026
        1. 6.5.4.1. Asia Pacific Therapeutic Drug Monitoring Market, by Technology, 2016-2026 (USD Million)
      5. 6.5.5. Asia Pacific Therapeutic Drug Monitoring Market, by Class of Drug, 2016-2026
        1. 6.5.5.1. Asia Pacific Therapeutic Drug Monitoring Market, by Class of Drug, 2016-2026 (USD Million)
      6. 6.5.6. Asia Pacific Therapeutic Drug Monitoring Market, by End User, 2016-2026
        1. 6.5.6.1. Asia Pacific Therapeutic Drug Monitoring Market, by End User, 2016-2026 (USD Million)
      7. 6.5.7. China
        1. 6.5.7.1. China Market size and forecast, 2016-2026 (USD Million)
      8. 6.5.8. Japan
        1. 6.5.8.1. Japan Market size and forecast, 2016-2026 (USD Million)
      9. 6.5.9. India
        1. 6.5.9.1. India Market size and forecast, 2016-2026 (USD Million)
      10. 6.5.10. South Korea
        1. 6.5.10.1. South Korea Market size and forecast, 2016-2026 (USD Million)
      11. 6.5.11. South-East Asia
        1. 6.5.11.1. South-East Asia Market size and forecast, 2016-2026 (USD Million)
      12. 6.5.12. Rest of Asia Pacific
        1. 6.5.12.1. Rest of Asia Pacific Market size and forecast, 2016-2026 (USD Million)
    6. 6.6. Latin America
      1. 6.6.1. Latin America Therapeutic Drug Monitoring Market size and forecast, 2016-2026
      2. 6.6.2. Latin America Therapeutic Drug Monitoring Market, by Country, 2018 & 2025 (USD Million)
      3. 6.6.3. Latin America Therapeutic Drug Monitoring Market, by Product, 2016-2026
        1. 6.6.3.1. Latin America Therapeutic Drug Monitoring Market, by Product, 2016-2026 (USD Million)
      4. 6.6.4. Latin America Therapeutic Drug Monitoring Market, by Technology, 2016-2026
        1. 6.6.4.1. Latin America Therapeutic Drug Monitoring Market, by Technology, 2016-2026 (USD Million)
      5. 6.6.5. Latin America Therapeutic Drug Monitoring Market, by Class of Drug, 2016-2026
        1. 6.6.5.1. Latin America Therapeutic Drug Monitoring Market, by Class of Drug, 2016-2026 (USD Million)
      6. 6.6.6. Latin America Therapeutic Drug Monitoring Market, by End User, 2016-2026
        1. 6.6.6.1. Latin America Therapeutic Drug Monitoring Market, by End User, 2016-2026 (USD Million)
      7. 6.6.7. Brazil
        1. 6.6.7.1. Brazil Market size and forecast, 2016-2026 (USD Million)
      8. 6.6.8. Mexico
        1. 6.6.8.1. Mexico Market size and forecast, 2016-2026 (USD Million)
      9. 6.6.9. Rest of Latin America
        1. 6.6.9.1. Rest of Latin America Market size and forecast, 2016-2026 (USD Million)
    7. 6.7. The Middle-East and Africa
      1. 6.7.1. The Middle-East and Africa Therapeutic Drug Monitoring Market size and forecast, 2016-2026
      2. 6.7.2. The Middle-East and Africa Therapeutic Drug Monitoring Market, by Country, 2018 & 2025 (USD Million)
      3. 6.7.3. The Middle-East and Africa Therapeutic Drug Monitoring Market, by Product, 2016-2026
        1. 6.7.3.1. The Middle-East and Africa Therapeutic Drug Monitoring Market, by Product, 2016-2026 (USD Million)
      4. 6.7.4. The Middle-East and Africa Therapeutic Drug Monitoring Market, by Technology, 2016-2026
        1. 6.7.4.1. The Middle-East and Africa Therapeutic Drug Monitoring Market, by Technology, 2016-2026 (USD Million)
      5. 6.7.5. The Middle-East and Africa Therapeutic Drug Monitoring Market, by Class of Drug, 2016-2026
        1. 6.7.5.1. The Middle-East and Africa Therapeutic Drug Monitoring Market, by Class of Drug, 2016-2026 (USD Million)
      6. 6.7.6. The Middle-East and Africa Therapeutic Drug Monitoring Market, by End User, 2016-2026
        1. 6.7.6.1. The Middle-East and Africa Therapeutic Drug Monitoring Market, by End User, 2016-2026 (USD Million)
      7. 6.7.7. GCC Countries
        1. 6.7.7.1. GCC Countries Market size and forecast, 2016-2026 (USD Million)
      8. 6.7.8. South Africa
        1. 6.7.8.1. South Africa Market size and forecast, 2016-2026 (USD Million)
      9. 6.7.9. Rest of Middle-East Africa
        1. 6.7.9.1. Rest of Middle-East Africa Market size and forecast, 2016-2026 (USD Million)
  7. CHAPTER 7. Therapeutic Drug Monitoring market – Competitive Landscape
    1. 7.1. Competitor Market Share – Revenue
    2. 7.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 7.3. Strategic Development
      1. 7.3.1. Acquisitions and Mergers
      2. 7.3.2. New Products
      3. 7.3.3. Research & Development Activities
  8. CHAPTER 8. Company Profiles
    1. 8.1. Abbott Laboratories
      1. 8.1.1. Company Overview
      2. 8.1.2. Abbott Laboratories Revenue and Gross Margin
      3. 8.1.3. Product portfolio
      4. 8.1.4. Recent initiatives
    2. 8.2. Danaher Corporation
      1. 8.2.1. Company Overview
      2. 8.2.2. Danaher Corporation Revenue and Gross Margin
      3. 8.2.3. Product portfolio
      4. 8.2.4. Recent initiatives
    3. 8.3. Biomérieux
      1. 8.3.1. Company Overview
      2. 8.3.2. Biomérieux Revenue and Gross Margin
      3. 8.3.3. Product portfolio
      4. 8.3.4. Recent initiatives
    4. 8.4. Bühlmann Laboratories
      1. 8.4.1. Company Overview
      2. 8.4.2. Bühlmann Laboratories Revenue and Gross Margin
      3. 8.4.3. Product portfolio
      4. 8.4.4. Recent initiatives
    5. 8.5. Randox Laboratories Hoffmann-La Roche
      1. 8.5.1. Company Overview
      2. 8.5.2. Randox Laboratories Hoffmann-La Roche Revenue and Gross Margin
      3. 8.5.3. Product portfolio
      4. 8.5.4. Recent initiatives
    6. 8.6. Siemens Healthineers
      1. 8.6.1. Company Overview
      2. 8.6.2. Siemens Healthineers Revenue and Gross Margin
      3. 8.6.3. Product portfolio
      4. 8.6.4. Recent initiatives
    7. 8.7. Thermo Fisher Scientific
      1. 8.7.1. Company Overview
      2. 8.7.2. Thermo Fisher Scientific Revenue and Gross Margin
      3. 8.7.3. Product portfolio
      4. 8.7.4. Recent initiatives
    8. 8.8. Bio-Rad Laboratories
      1. 8.8.1. Company Overview
      2. 8.8.2. Bio-Rad Laboratories Revenue and Gross Margin
      3. 8.8.3. Product portfolio
      4. 8.8.4. Recent initiatives
    9. 8.9. Sekisui Medical
      1. 8.9.1. Company Overview
      2. 8.9.2. Sekisui Medical Revenue and Gross Margin
      3. 8.9.3. Product portfolio
      4. 8.9.4. Recent initiatives
  9. CHAPTER 9. Therapeutic Drug Monitoring — Industry Analysis
    1. 9.1. Therapeutic Drug Monitoring Market – Key Trends
      1. 9.1.1. Market Drivers
      2. 9.1.2. Market Restraints
      3. 9.1.3. Market Opportunities
    2. 9.2. Value Chain Analysis
    3. 9.3. Technology Roadmap and Timeline
    4. 9.4. Therapeutic Drug Monitoring Market – Attractiveness Analysis
      1. 9.4.1. By Product
      2. 9.4.2. By Technology
      3. 9.4.3. By Class of Drug
      4. 9.4.4. By End User
      5. 9.4.5. By Region
  10. CHAPTER 10. Strategic Inputs and Impact Analysis
    1. 10.1. COVID-19 Impacts on Therapeutic Drug Monitoring Industry
      1. 10.1.1. COVID-19 Short-Term Impact & Business Strategies
      2. 10.1.2. COVID-19 Mid-Term Impact & Business Strategies
      3. 10.1.3. COVID-19 Long-Term Impact & Business Strategies
    2. 10.2. Some of the major parameters affecting the market are:
    3. 10.3. Pipeline Analysis COVID-19 Specific:
      1. 10.3.1. Drugs
      2. 10.3.2. Vaccines
  11. CHAPTER 11. Marketing Strategy Analysis, Distributors
    1. 11.1. Marketing Channel
    2. 11.2. Direct Marketing
    3. 11.3. Indirect Marketing
    4. 11.4. Marketing Channel Development Trend
    5. 11.5. Economic/Political Environmental Change
  12. CHAPTER 12. Report Conclusion
  13. CHAPTER 13. Research Approach & Methodology
    1. 13.1. Report Description
    2. 13.2. Research Scope
    3. 13.3. Research Methodology
      1. 13.3.1. Secondary Research
      2. 13.3.2. Primary Research
      3. 13.3.3. Models
        1. 13.3.3.1. Company Share Analysis Model
        2. 13.3.3.2. Revenue Based Modeling
        3. 13.3.3.3. Research Limitations

        List of Figures

        FIG. 1 Global Therapeutic Drug Monitoring  Market, 2016-2026 (USD Million)
        FIG. 2 Global Therapeutic Drug Monitoring  Market Share, by Product, 2018 & 2025 (USD Million)
        FIG. 3 Global Consumables  Therapeutic Drug Monitoring  Market, 2016-2026 (USD Million)
        FIG. 4 Global Equipment Therapeutic Drug Monitoring  Market, 2016-2026 (USD Million)
        FIG. 5 Global Therapeutic Drug Monitoring  Market Share, by Technology, 2018 & 2025 (USD Million)
        FIG. 6 Global Immunoassays  Therapeutic Drug Monitoring  Market, 2016-2026 (USD Million)
        FIG. 7 Global Colorimetric Immunoassays Therapeutic Drug Monitoring  Market, 2016-2026 (USD Million)
        FIG. 8 Global Radioimmunoassays Therapeutic Drug Monitoring  Market, 2016-2026 (USD Million)
        FIG. 9 Global Other immunoassays Therapeutic Drug Monitoring  Market, 2016-2026 (USD Million)
        FIG. 10 Global Chromatography-MS Therapeutic Drug Monitoring  Market, 2016-2026 (USD Million)
        FIG. 11 Global Therapeutic Drug Monitoring  Market Share, by Class of Drug, 2018 & 2025 (USD Million)
        FIG. 12 Global Antiepileptic drugs Therapeutic Drug Monitoring  Market, 2016-2026 (USD Million)
        FIG. 13 Global Antiarrhythmic drugs Therapeutic Drug Monitoring  Market, 2016-2026 (USD Million)
        FIG. 14 Global Immunosuppressant drugs Therapeutic Drug Monitoring  Market, 2016-2026 (USD Million)
        FIG. 15 Global Antibiotic drugs Therapeutic Drug Monitoring  Market, 2016-2026 (USD Million)
        FIG. 16 Global Bronchodilator drugs Therapeutic Drug Monitoring  Market, 2016-2026 (USD Million)
        FIG. 17 Global Psychoactive drugs Therapeutic Drug Monitoring  Market, 2016-2026 (USD Million)
        FIG. 18 Global Other drug classes Therapeutic Drug Monitoring  Market, 2016-2026 (USD Million)
        FIG. 19 Global Therapeutic Drug Monitoring  Market Share, by End User, 2018 & 2025 (USD Million)
        FIG. 20 Global Hospital laboratories Therapeutic Drug Monitoring  Market, 2016-2026 (USD Million)
        FIG. 21 Global Commercial/private laboratories Therapeutic Drug Monitoring  Market, 2016-2026 (USD Million)
        FIG. 22 Global Others Therapeutic Drug Monitoring  Market, 2016-2026 (USD Million)
        FIG. 23 Global Therapeutic Drug Monitoring  Market Share, by Region, 2018 & 2025
        FIG. 24 North America Therapeutic Drug Monitoring  Market, 2016-2026
        FIG. 25 U.S. Therapeutic Drug Monitoring  Market, 2016-2026
        FIG. 26 Canada Therapeutic Drug Monitoring  Market, 2016-2026
        FIG. 27 Europe Therapeutic Drug Monitoring  Market, 2016-2026
        FIG. 28 Germany Therapeutic Drug Monitoring  Market, 2016-2026
        FIG. 29 France Therapeutic Drug Monitoring  Market, 2016-2026
        FIG. 30 U.K. Therapeutic Drug Monitoring  Market, 2016-2026
        FIG. 31 Italy Therapeutic Drug Monitoring  Market, 2016-2026
        FIG. 32 Spain Therapeutic Drug Monitoring  Market, 2016-2026
        FIG. 33 Rest of Europe Therapeutic Drug Monitoring  Market, 2016-2026
        FIG. 34 Asia Pacific Therapeutic Drug Monitoring  Market, 2016-2026
        FIG. 35 China Therapeutic Drug Monitoring  Market, 2016-2026
        FIG. 36 Japan Therapeutic Drug Monitoring  Market, 2016-2026
        FIG. 37 India Therapeutic Drug Monitoring  Market, 2016-2026
        FIG. 38 South  Korea Therapeutic Drug Monitoring  Market, 2016-2026
        FIG. 39 South-East Asia Therapeutic Drug Monitoring  Market, 2016-2026
        FIG. 40 Rest of Asia Pacific Therapeutic Drug Monitoring  Market, 2016-2026
        FIG. 41 Latin America Therapeutic Drug Monitoring  Market, 2016-2026
        FIG. 42 Brazil Therapeutic Drug Monitoring  Market, 2016-2026
        FIG. 43 Mexico Therapeutic Drug Monitoring  Market, 2016-2026
        FIG. 44 Rest of Latin America Therapeutic Drug Monitoring  Market, 2016-2026
        FIG. 45 The Middle-East and Africa Therapeutic Drug Monitoring  Market, 2016-2026
        FIG. 46 GCC Countries Therapeutic Drug Monitoring  Market, 2016-2026
        FIG. 47 South Africa Therapeutic Drug Monitoring  Market, 2016-2026
        FIG. 48 Rest of Middle-East Africa Therapeutic Drug Monitoring  Market, 2016-2026
        FIG. 49 Competitor Market Share – Revenue
        FIG. 50 Abbott Laboratories Revenue and Growth Rate
        FIG. 51 Abbott Laboratories Market Share
        FIG. 52 Danaher Corporation Revenue and Growth Rate
        FIG. 53 Danaher Corporation Market Share
        FIG. 54 Biomérieux Revenue and Growth Rate
        FIG. 55 Biomérieux Market Share
        FIG. 56 Bühlmann Laboratories Revenue and Growth Rate
        FIG. 57 Bühlmann Laboratories Market Share
        FIG. 58 Randox Laboratories Hoffmann-La Roche Revenue and Growth Rate
        FIG. 59 Randox Laboratories Hoffmann-La Roche Market Share
        FIG. 60 Siemens Healthineers Revenue and Growth Rate
        FIG. 61 Siemens Healthineers Market Share
        FIG. 62 Thermo Fisher Scientific Revenue and Growth Rate
        FIG. 63 Thermo Fisher Scientific Market Share
        FIG. 64 Bio-Rad Laboratories Revenue and Growth Rate
        FIG. 65 Bio-Rad Laboratories Market Share
        FIG. 66 Sekisui Medical Revenue and Growth Rate
        FIG. 67 Sekisui Medical Market Share
        FIG. 68 Market Dynamics
        FIG. 69 Global Therapeutic Drug Monitoring  – Value Chain Analysis
        FIG. 70 Technology Roadmap and Timeline
        FIG. 71 Market Attractiveness Analysis – By Product
        FIG. 72 Market Attractiveness Analysis – By Technology
        FIG. 73 Market Attractiveness Analysis – By Class of Drug
        FIG. 74 Market Attractiveness Analysis – By End User
        FIG. 75 Market Attractiveness Analysis – By Region
        FIG. 76 Market Channel
        FIG. 77 Marketing Channel Development Trend
        FIG. 78 Growth in World Gross Product, 2008-2018

        List of Tables

        TABLE 1 Global Therapeutic Drug Monitoring  Market, 2018 & 2025 (USD Million)
        TABLE 2 Global Therapeutic Drug Monitoring  market, by Product, 2016-2026 (USD Million)
        TABLE 3 Global Therapeutic Drug Monitoring  market, by Technology, 2016-2026 (USD Million)
        TABLE 4 Global Therapeutic Drug Monitoring  market, by Class of Drug, 2016-2026 (USD Million)
        TABLE 5 Global Therapeutic Drug Monitoring  market, by End User, 2016-2026 (USD Million)
        TABLE 6 Global Therapeutic Drug Monitoring  market, by Region, 2016-2026 (USD Million)
        TABLE 7 North America Therapeutic Drug Monitoring  Market, by Product, 2016-2026 (USD Million)
        TABLE 8 North America Therapeutic Drug Monitoring  Market, by Technology, 2016-2026 (USD Million)
        TABLE 9 North America Therapeutic Drug Monitoring  Market, by Class of Drug, 2016-2026 (USD Million)
        TABLE 10 North America Therapeutic Drug Monitoring  Market, by End User, 2016-2026 (USD Million)
        TABLE 11 Europe Therapeutic Drug Monitoring  Market, by Product, 2016-2026 (USD Million)
        TABLE 12 Europe Therapeutic Drug Monitoring  Market, by Technology, 2016-2026 (USD Million)
        TABLE 13 Europe Therapeutic Drug Monitoring  Market, by Class of Drug, 2016-2026 (USD Million)
        TABLE 14 Europe Therapeutic Drug Monitoring  Market, by End User, 2016-2026 (USD Million)
        TABLE 15 Asia Pacific Therapeutic Drug Monitoring  Market, by Product, 2016-2026 (USD Million)
        TABLE 16 Asia Pacific Therapeutic Drug Monitoring  Market, by Technology, 2016-2026 (USD Million)
        TABLE 17 Asia Pacific Therapeutic Drug Monitoring  Market, by Class of Drug, 2016-2026 (USD Million)
        TABLE 18 Asia Pacific Therapeutic Drug Monitoring  Market, by End User, 2016-2026 (USD Million)
        TABLE 19 Latin America Therapeutic Drug Monitoring  Market, by Product, 2016-2026 (USD Million)
        TABLE 20 Latin America Therapeutic Drug Monitoring  Market, by Technology, 2016-2026 (USD Million)
        TABLE 21 Latin America Therapeutic Drug Monitoring  Market, by Class of Drug, 2016-2026 (USD Million)
        TABLE 22 Latin America Therapeutic Drug Monitoring  Market, by End User, 2016-2026 (USD Million)
        TABLE 23 The Middle-East and Africa Therapeutic Drug Monitoring  Market, by Product, 2016-2026 (USD Million)
        TABLE 24 The Middle-East and Africa Therapeutic Drug Monitoring  Market, by Technology, 2016-2026 (USD Million)
        TABLE 25 The Middle-East and Africa Therapeutic Drug Monitoring  Market, by Class of Drug, 2016-2026 (USD Million)
        TABLE 26 The Middle-East and Africa Therapeutic Drug Monitoring  Market, by End User, 2016-2026 (USD Million)
        TABLE 27 Global Therapeutic Drug Monitoring  Market - Company Revenue Analysis 2016-2019 (USD Million)
        TABLE 28 Global Therapeutic Drug Monitoring  Market - Company Revenue Share Analysis 2016-2019(%)
        TABLE 29 Acquisitions and Mergers
        TABLE 30 New Product/Service Launch
        TABLE 31 Research & Development Activities
        TABLE 32 Market Drivers
        TABLE 33 Market Restraints
        TABLE 34 Market Opportunities
        

Covid-19

Therapeutic Drug Monitoring Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Major Market Players

  • Abbott Laboratories
  •  Danaher Corporation
  •  Biomérieux
  •  Bühlmann Laboratories
  •  Randox Laboratories Hoffmann-La Roche
  •  Siemens Healthineers
  •  Thermo Fisher Scientific
  •  Bio-Rad Laboratories
  •  Sekisui Medical

Frequently Asked Questions

Strict enforcement of laws by government authorities mandating Therapeutic Drug Monitoring Market.
According to Facts and Factors research report, the global Therapeutic Drug Monitoring Market accrued earnings worth approximately XX (USD Billion) in 2020 and is predicted to gain revenue of about XX(USD Billion) by 2028, is set to record a CAGR of nearly XX% over the period from 2021 to 2028.
North America will contribute lucratively towards the global market value over the estimated timeline. The regional market surge is subject to large-scale presence of giant participants in countries such as the U.S. Apart from this, favorable compensation policies along with high acceptance of new Therapeutic Drug Monitoring Market will drive regional market trends. With regional governments enforcing strict laws pertaining to drug abuse, the market for Therapeutic Drug Monitoring Market in North America is set to witness exponential growth over years to come. Legalization of cannabis in countries such as Canada and U.S. through passing of acts in parliament is likely to enlarge scope of Therapeutic Drug Monitoring Market in North America over coming decade.
why choose fnf
key questions answers

Related Reports

report img

Medical Device Market Report s, 2021 - 2026

[205+ Pages Report] The latest market study published by Facts Factors titled Medical Device Market contains the latestabout the market in terms of an analytical approach. We estimate that the globalMedical Device Market will flourish at an astounding rate of 5% CAGR during the forecast period to...

Published Date : 21-Jun-2021 | | Category : | Pages : 205 | Format : Read more

Inquiry for Buying Request Sample
report img

3D Printed Medical Devices Market Report s, 2021 – 2026

[191+ Pages Report] As per the latest research and survey report issued by Facts and Factors, the global3D printed medical devices market was valued at around USD 1.9 Billion in 2020 and is expected to register revenues worth USD 4 Billion by the end of 2026, growing at an exceptional CAGR of appr...

Published Date : 27-May-2021 | | Category : | Pages : 191 | Format : Read more

Inquiry for Buying Request Sample